&w=3840&q=100)
'Our fair price on Nifty50 is around 28,000 over the next 12 months'
Sai Aravindh Mumbai
Listen to This Article
Corporate results for the March 2025 quarter have not disappointed. JASPREET SINGH ARORA, chief investment officer at Equentis Wealth Advisory Services, tells Sai Aravindh in an email interview that the market is factoring in approximately 14 per cent earnings growth for the Nifty50 for FY26 despite multiple earnings downgrades over recent quarters. Edited excerpts:
Did the fourth-quarter earnings meet your expectations? What is your outlook for the financial year 2026?
India Inc's Q4 FY25 earnings have been largely mixed. Around 50 per cent of Nifty50 companies exceeded street expectations, nearly 30 per cent missed estimates, and the remainder delivered neutral
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
27 minutes ago
- Mint
Top Losers and Gainers on Aug 08: PG Electroplast, Kalyan Jewellers, Biocon, Coforge, Mazagon Dock among top losers
The Indian stock market posted sharp losses in Friday's session, August 8, extending the benchmark indices' weekly losing streak to six weeks, the worst trend bulls have seen in the last five years, indicating sustained selling across the broad. Investor sentiment continues to remain weak amid higher tariffs imposed by US President Donald Trump, disappointing June-quarter earnings so far, and the absence of fresh market triggers, causing Indian stocks to fall to levels not seen since early May and to break key support levels. The Nifty 50 fell 1% to 24,352 points, ending the week with a 0.90% drop, its sixth straight weekly loss. The S&P BSE Sensex also closed 1% lower, falling below the 80K to 79,840, extending its weekly decline. In a more severe blow, the broader markets suffered deeper cuts, with the Nifty Midcap 100 and Nifty Smallcap 100 indices each losing over 1.7% and taking their weekly losses to more than 1.5%.
Business Standard
35 minutes ago
- Business Standard
Benchmarks trade with deep cuts; pharma shares drop
The key equity indices continued to trade with significant cuts in the early afternoon trade, witnessing selling pressure as investors remained cautious amid concerns over the impact of Trumps tariff decision. Market sentiment turned risk-averse, with participants adopting a risk-off approach. Going forward, investors will closely monitor crude oil prices, FII activity and development on the tariff front. The Nifty hovered below the 24,450 mark. Pharma shares declined after advancing in the past trading session. At 12:25 IST, the barometer index, the S&P BSE Sensex dropped 575.35 points or 0.71% to 80,044.96. The Nifty 50 index declined 172.45 points or 0.70% to 24,424.10. In the broader market, the S&P BSE Mid-Cap index declined 0.89% and the S&P BSE Small-Cap index fell 0.35%. The market breadth was negative. On the BSE, 1,714 shares rose and 2,128 shares fell. A total of 153 shares were unchanged. Derivatives: The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, up 2.01% to 11.92. The Nifty 28 August 2025 futures were trading at 24,498.90 at a premium of 74.8 points as compared with the spot at 24,424.10. The Nifty option chain for the 28 August 2025 expiry showed a maximum call OI of 64.2 lakh contracts at the 25,000 strike price. Maximum put OI of 43 lakh contracts was seen at 24,000 strike price. Buzzing Index: The Nifty Pharma index declined 0.81% to 21,510. The index rose 0.75% in the past trading session. Biocon (down 3.89%), Natco Pharma (down 2.39%), Divis Laboratories (down 1.8%), Mankind Pharma (down 1.69%), Aurobindo Pharma (down 1.3%), Alkem Laboratories (down 1.27%), Glenmark Pharmaceuticals (down 1.19%), Gland Pharma (down 0.92%), Granules India (down 0.92%) and Laurus Labs (down 0.78%) tumbled. Stocks in Spotlight: KRBL surged 10.40% after the companys consolidated net profit jumped 74% to Rs 150.58 crore on 32.1% increase in net sales to Rs 1,584.35 crore in Q1 June 2025 over Q1 June 2024. Data Patterns (India) tumbled 6.72% after the companys standalone net profit fell 22.23% to Rs 25.50 crore in Q1 FY26, compared to Rs 32.79 crore posted in Q1 FY25. Revenue from operations declined 4.56% year-on-year (YoY) to Rs 99.33 crore in the quarter ended 30 June 2025.
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
Infy, Adani Ent, Cochin Ship among 5 oversold stocks; trading strategy here
Infosys, Adani Enterprises, Cochin Shipyard, IFCI and UCO Bank are technically trading in the oversold zone, as per the RSI indicator; charts hint up to 23% downside risk for these 5 stocks. Rex Cano Mumbai Listen to This Article Equity markets in India have been under pressure amid the US tariff worries in recent trading sessions. The National Stock Exchange (NSE) benchmark - Nifty 50 index has shed 5 per cent from its 2025 high of 25,669 in little more than a month. Similarly, the broader Nifty 500 index too has declined around 5 per cent from its calendar year peak. Amid this broad-based sell-off several stocks are now seen trading in oversold territory on the technical charts. A study of the Nifty 500 stocks reveals that as of today (Friday) 35 out of the
